To identify the MPE mediator(s) downstream of mutant KRAS and to tease out the transcriptional signature of mutant KRAS on tumour cells, we performed comparative microarray-based transcriptome profiling of Kras-mutant and wild-type mouse tumour cells versus benign airway cells. Here, KRAS is linked to neoplasm.